Levmentin Adultes (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, causing cell lysis. Clavulanic acid inhibits beta‑lactamase enzymes produced by resistant bacteria, protecting amoxicillin from degradation and extending its activity against beta‑lactamase‑producing strains.

The dosage of Levmentin Adultes is determined by the prescribing clinician based on the type and severity of infection, patient weight, renal function, and local antimicrobial guidelines. No fixed regimen is provided here; the prescriber sets the appropriate dose and infusion rate.

Safety data for intravenous amoxicillin/clavulanic acid in pregnancy and lactation are limited. Clinicians should weigh the potential benefits against possible risks and consider alternative therapies when appropriate. If used, close monitoring of the mother and fetus or infant is advised.

To place an order, submit an enquiry on the Levmentin Adultes product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and required import documentation.

Levmentin Adultes combines a broad‑spectrum penicillin (amoxicillin) with a beta‑lactamase inhibitor (clavulanic acid), offering activity against many beta‑lactamase‑producing organisms that plain amoxicillin cannot cover. Compared with cephalosporins, it provides a similar spectrum for Gram‑positive and some Gram‑negative pathogens but may be preferred when beta‑lactamase resistance is suspected.

The product should be stored at 2‑8 °C, kept refrigerated, protected from light, and not frozen. Once reconstituted, use according to the manufacturer’s stability guidelines and discard any unused portion after the recommended time to maintain sterility.

Levmentin Adultes is given by intravenous infusion. The prepared solution is administered over a period defined by the prescriber, typically ranging from 30 minutes to several hours, depending on the infection severity and patient tolerance.

Serious adverse events include anaphylaxis or severe allergic reactions, acute hepatic injury, Clostridioides difficile‑associated colitis, and rare skin disorders such as Stevens‑Johnson syndrome. Patients should be monitored for signs of rash, jaundice, gastrointestinal upset, or respiratory distress, and treatment should be stopped if severe reactions occur.

Levmentin Adultes is contraindicated in individuals with a known hypersensitivity to amoxicillin, clavulanic acid, or any other beta‑lactam antibiotics. Caution is also advised for patients with severe hepatic impairment or a history of severe allergic reactions to related drugs.